BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11709456)

  • 1. Difference in B cell activation between dermatomyositis and polymyositis: analysis of the expression of RP105 on peripheral blood B cells.
    Kikuchi Y; Koarada S; Tada Y; Ushiyama O; Morito F; Suzuki N; Ohta A; Horiuchi T; Miyake K; Nagasawa K
    Ann Rheum Dis; 2001 Dec; 60(12):1137-40. PubMed ID: 11709456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell receptor BV gene repertoire of lymphocytes in bronchoalveolar lavage fluid of polymyositis/dermatomyositis patients with interstitial pneumonitis.
    Chino Y; Murata H; Goto D; Matsumoto I; Tsutsumi A; Sakamoto T; Ohtsuka M; Sekisawa K; Ito S; Sumida T
    Int J Mol Med; 2006 Jan; 17(1):101-9. PubMed ID: 16328018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis.
    Kurasawa K; Nawata Y; Takabayashi K; Kumano K; Kita Y; Takiguchi Y; Kuriyama T; Sueishi M; Saito Y; Iwamoto I
    Clin Exp Immunol; 2002 Sep; 129(3):541-8. PubMed ID: 12197897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis.
    Shimojima Y; Matsuda M; Ishii W; Kishida D; Sekijima Y
    Autoimmunity; 2017 Dec; 50(8):481-490. PubMed ID: 29172719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
    Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
    Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia.
    Kourakata H; Takada T; Suzuki E; Enomoto K; Saito I; Taguchi Y; Tsukada H; Nakano M; Arakawa M
    Respirology; 1999 Sep; 4(3):223-8. PubMed ID: 10489663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of lymphocyte subpopulations and TH1/TH2 balance in patients with polymyositis and dermatomyositis.
    Ishii W; Matsuda M; Shimojima Y; Itoh S; Sumida T; Ikeda S
    Intern Med; 2008; 47(18):1593-9. PubMed ID: 18797118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia--with or without PM/DM.
    Takato H; Waseda Y; Watanabe S; Inuzuka K; Katayama N; Ichikawa Y; Yasui M; Fujimura M
    Respir Med; 2013 Jan; 107(1):128-33. PubMed ID: 23137883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of autophagy in T‑cell survival in polymyositis and dermatomyositis.
    Shu X; Chen F; Peng Q; Lu X; Tian X; Wang Y; Wang G
    Mol Med Rep; 2017 Aug; 16(2):1180-1188. PubMed ID: 28586060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis.
    Feng M; Guo H; Zhang C; Wang Y; Liang Z; Zhao X; Qin Y; Wu Y; Liu G; Gao C; Luo J
    Int Immunopharmacol; 2019 Dec; 77():105912. PubMed ID: 31669890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-lymphocyte immunophenotyping in polymyositis and dermatomyositis.
    Iannone F; Cauli A; Yanni G; Kingsley GH; Isenberg DA; Corrigall V; Panayi GS
    Br J Rheumatol; 1996 Sep; 35(9):839-45. PubMed ID: 8810666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis.
    Aleksza M; Szegedi A; Antal-Szalmás P; Irinyi B; Gergely L; Ponyi A; Hunyadi J; Sipka S; Zeher M; Szegedi G; Dankó K
    Ann Rheum Dis; 2005 Oct; 64(10):1485-9. PubMed ID: 15829578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
    Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
    J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial lung disease in polymyositis and dermatomyositis.
    Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
    Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of peripheral blood lymphocyte subsets in patients with polymyositis and dermatomyositis.
    Wang DX; Lu X; Zu N; Lin B; Wang LY; Shu XM; Ma L; Wang GC
    Clin Rheumatol; 2012 Dec; 31(12):1691-7. PubMed ID: 22933126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus.
    Koarada S; Tada Y; Ushiyama O; Morito F; Suzuki N; Ohta A; Miyake K; Kimoto M; Nagasawa K
    Arthritis Rheum; 1999 Dec; 42(12):2593-600. PubMed ID: 10616005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-35: A Serological Biomarker for Patients with Polymyositis/Dermatomyositis.
    Jiang Q; Li Y; Xia L; Shen H; Lu J
    J Interferon Cytokine Res; 2019 Nov; 39(11):720-725. PubMed ID: 31274382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of RP105-lacking activated B cells in the peripheral blood and salivary glands in patients with Sjögren's syndrome.
    Kikuchi Y; Koarada S; Nakamura S; Yonemitsu N; Tada Y; Haruta Y; Morito F; Ohta A; Miyake K; Horiuchi T; Nagasawa K
    Clin Exp Rheumatol; 2008; 26(1):5-12. PubMed ID: 18328140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.
    Chen Z; Cao M; Plana MN; Liang J; Cai H; Kuwana M; Sun L
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1316-24. PubMed ID: 23908005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.